nl_id,docebo_id,docebo_code,newTest_ID,newQues_ID,sequence,question_text,newQuesAns_ID,answer_sequence,answer_text,correct,course_name
15600,9380,Elearning-0000-622,g9862,g50672,0,Which of the following describes indirect/unconjugated bilirubin?,g166399,0,Fat soluble,1,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50672,1,Which of the following describes indirect/unconjugated bilirubin?,g166400,1,Non-toxic,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50672,2,Which of the following describes indirect/unconjugated bilirubin?,g166401,2,Water soluble,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50672,3,Which of the following describes indirect/unconjugated bilirubin?,g166402,3,Excreted in the urine and stool,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50673,0,Which of the following describes direct/conjugated bilirubin?,g166403,0,Water soluble,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50673,1,Which of the following describes direct/conjugated bilirubin?,g166404,1,Non-toxic,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50673,2,Which of the following describes direct/conjugated bilirubin?,g166405,2,Excreted from the liver as a component of bile,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50673,3,Which of the following describes direct/conjugated bilirubin?,g166406,3,All of the above,1,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50674,0,If you see jaundice before the infant is 24 hours of age it is pathological jaundice.,g166407,0,TRUE,1,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50674,1,If you see jaundice before the infant is 24 hours of age it is pathological jaundice.,g166408,1,FALSE,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50675,0,f you see jaundice after 24 hours of life it is physiological and it is not clinically significant.,g166409,0,TRUE,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50675,1,f you see jaundice after 24 hours of life it is physiological and it is not clinically significant.,g166410,1,FALSE,1,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50676,0,Physiological jaundice is the result of which of the following?,g166411,0,Increased red blood cell destruction,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50676,1,Physiological jaundice is the result of which of the following?,g166412,1,Immature liver function in the newborn,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50676,2,Physiological jaundice is the result of which of the following?,g166413,2,Another disease process,0,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15600,9380,Elearning-0000-622,g9862,g50676,3,Physiological jaundice is the result of which of the following?,g166414,3,A and B only,1,FCC RESIDENCY NEWBORN JAUNDICE AND PHOTOTHERAPY FY2020
15599,9379,Elearning-0000-621,g9861,g50666,0,Sepsis is defined as which of the following:,g166374,0,SIRS + infection,1,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50666,1,Sepsis is defined as which of the following:,g166375,1,Presence of highly infectious bacteria in the blood,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50666,2,Sepsis is defined as which of the following:,g166376,2,System wide infection causing organ dysfunction,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50666,3,Sepsis is defined as which of the following:,g166377,3,Septic shock,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50667,0,Risk factors for sepsis in the post-partum population include which of the following:,g166378,0,Diabetes,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50667,1,Risk factors for sepsis in the post-partum population include which of the following:,g166379,1,Hypertension,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50667,2,Risk factors for sepsis in the post-partum population include which of the following:,g166380,2,Obesity,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50667,3,Risk factors for sepsis in the post-partum population include which of the following:,g166381,3,Use of antibiotics within 2 weeks before delivery,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50667,4,Risk factors for sepsis in the post-partum population include which of the following:,g166382,4,All of the above,1,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50668,0,Which of the following lab results indicates cell injury?,g166383,0,"Platelets  80,000",0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50668,1,Which of the following lab results indicates cell injury?,g166384,1,Creatinine 4,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50668,2,Which of the following lab results indicates cell injury?,g166385,2,"WBC 3,500",0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50668,3,Which of the following lab results indicates cell injury?,g166386,3,All of the above,1,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50669,0,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,g166387,0,Notify MD for further orders,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50669,1,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,g166388,1,Draw a stat serum lactate,1,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50669,2,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,g166389,2,Notify the Clinical Supervisor and assess patientΓÇÖs vital signs every 4 hour,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50669,3,You are caring for a patient and her heart rate is 95 and respiratory rate is 22. She tells you that she was taking Macrobid for a UTI a week before she delivered. What is the appropriate nursing action?,g166390,3,None of the above,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50670,0,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,g166391,0,Notify MD and clinical supervisor,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50670,1,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,g166392,1,"Nothing, a serum lactate of 3 is normal",0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50670,2,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,g166393,2,"Notify MD, get orders for blood cultures, broad spectrum antibiotics, and repeat lactate for 2 hrs",1,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50670,3,A serum lactate was drawn on your patient for suspected sepsis and it is 3. What is the appropriate nursing action?,g166394,3,Notify rapid response,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50671,0,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,g166395,0,2250 mls,1,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50671,1,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,g166396,1,500mls,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50671,2,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,g166397,2,225 mls,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15599,9379,Elearning-0000-621,g9861,g50671,3,Your patient weighs 75 kg. What is the appropriate amount for a fluid bolus according to the sepsis bundle?,g166398,3,1000 mls,0,FCC RESIDENCY MATERNAL SEPSIS FY2020
15598,9374,Elearning-0000-617,g9860,g50661,0,"During the first 24 hours Post-Partum, soaking an entire pad (side to side, top to bottom) every 15 minutes would be classified as a Post-Partum Hemorrhage",g166358,0,TRUE,1,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50661,1,"During the first 24 hours Post-Partum, soaking an entire pad (side to side, top to bottom) every 15 minutes would be classified as a Post-Partum Hemorrhage",g166359,1,FALSE,0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50662,0,"If you think your patient is hemorrhaging, you should begin vital sign assessments every 5 minutes.",g166360,0,TRUE,1,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50662,1,"If you think your patient is hemorrhaging, you should begin vital sign assessments every 5 minutes.",g166361,1,FALSE,0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50663,0,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",g166362,0,"Low BP, high MAP, Fatigue, Low H&H",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50663,1,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",g166363,1,"Low BP, high HR, low MAP, Pain",1,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50663,2,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",g166364,2,"Low BP, high HR, high MAP, Pain",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50663,3,"What physical signs and symptoms might a PPH patient exhibit that would make you suspicious of internal blood loss, even when there is no obvious external bleeding?",g166365,3,"Low BP, low HR, low MAP, decreased output",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50664,0,Which of the following are considered post-partum emergencies?,g166366,0,"Hemorrhage, sepsis and pneumonia",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50664,1,Which of the following are considered post-partum emergencies?,g166367,1,"Hemorrhage, pulmonary embolism and hypertensive crisis",1,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50664,2,Which of the following are considered post-partum emergencies?,g166368,2,"Hematoma, infection and sepsis",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50664,3,Which of the following are considered post-partum emergencies?,g166369,3,"Pulmonary edema, hematoma, and infection",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50665,0,The 4 TΓÇÖs of hemorrhage etiology are:,g166370,0,"Tone, trauma, trickle, thermoregulation",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50665,1,The 4 TΓÇÖs of hemorrhage etiology are:,g166371,1,"Tone, trauma, tissue, thrombosis",1,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50665,2,The 4 TΓÇÖs of hemorrhage etiology are:,g166372,2,"t-cells, trauma, trickle, thrombosis",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15598,9374,Elearning-0000-617,g9860,g50665,3,The 4 TΓÇÖs of hemorrhage etiology are:,g166373,3,"Tone, tolerance, tear, tension",0,FCC RESIDENCY POSTPARTUM EMERGENCIES FY2020
15591,8127,Elearning-0000-1024,g9855,g50596,1,What is data Security?,g166094,1,"b.  Sharing data from your home computer, only if you are connected to your personal secure wifi network",0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50596,2,What is data Security?,g166095,2,"c.  Ensuring that any tablet, phone or personal laptop that contains employees data is password protected",0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50596,0,What is data Security?,g166096,0,a.  Protecting data from destructive forces and the unwanted actions of unauthorized users,1,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50597,0,What departments are responsible for managing the integrity of Human Resource Data?,g166097,0,a.  Human Resource Department,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50597,1,What departments are responsible for managing the integrity of Human Resource Data?,g166098,1,b.  Position Management,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50597,2,What departments are responsible for managing the integrity of Human Resource Data?,g166099,2,c.  Position Control,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50597,3,What departments are responsible for managing the integrity of Human Resource Data?,g166100,3,d.  All Northside Hospital Departments,1,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50598,0,What should you do if you feel like you are a victim of phishing?,g166101,0,a.  Clear your computer history,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50598,1,What should you do if you feel like you are a victim of phishing?,g166102,1,b.  Delete the email,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50598,2,What should you do if you feel like you are a victim of phishing?,g166103,2,c.  Immediately notify the IS helpdesk,1,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50599,0,When is it appropriate to send patient information via personal email?,g166104,0,"a.  If the patient grants written and verbal permission, it is acceptable",0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50599,1,When is it appropriate to send patient information via personal email?,g166105,1,b.  If you are working from home and the information is requested by your supervisor,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50599,2,When is it appropriate to send patient information via personal email?,g166106,2,c.  You should never send patient information via personal email,1,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50600,0,"If a caller requests information regarding NSH employees, patients or data and you are unsure of the callers identity, how should you proceed?",g166107,0,a.  Provide the information and verify the callers identity at a later time,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50600,1,"If a caller requests information regarding NSH employees, patients or data and you are unsure of the callers identity, how should you proceed?",g166108,1,b.  Inform the caller that you cannot assist them and disconnect the call,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50600,2,"If a caller requests information regarding NSH employees, patients or data and you are unsure of the callers identity, how should you proceed?",g166109,2,c.  Request to call the customer back by using the number that is on the customer's file to verify the request.,1,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50601,0,What needs to be encrypted?,g166110,0,a.  All emails sent from a Northside email account,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50601,2,What needs to be encrypted?,g166111,2,c.  No emails are required to be encrypted,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50601,1,What needs to be encrypted?,g166112,1,"b.  Any message that contains sensitive material, such as personal health information (PHI), financial information, electronic medical records (EMRs), employee data, or just about anything related to patient care.",1,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50602,1,How can you manually encrypt messages from Northside?,g166113,1,b.  Type the phrase [secure] in the body of the email,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50602,2,How can you manually encrypt messages from Northside?,g166114,2,c.  Call the recipient and communicate to the recipient that the content of the email is secure,0,2020 HUMAN RESOURCE DATA SECURITY
15591,8127,Elearning-0000-1024,g9855,g50602,0,How can you manually encrypt messages from Northside?,g166115,0,a.  Type the phrase [secure] anywhere in the subject line of an email,1,2020 HUMAN RESOURCE DATA SECURITY
15587,9881,Questions-0000-17,g9852,g50536,0,Please list the location for this activity.,g165842,0,Atlanta,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50536,1,Please list the location for this activity.,g165843,1,Forsyth,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50536,2,Please list the location for this activity.,g165844,2,Cherokee,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50536,3,Please list the location for this activity.,g165845,3,Other,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50537,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g165846,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50537,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g165847,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50537,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g165848,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50537,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g165849,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50537,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g165850,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50538,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g165851,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50538,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g165852,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50538,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g165853,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50538,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g165854,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50538,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g165855,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50539,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g165856,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50539,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g165857,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50539,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g165858,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50539,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g165859,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50539,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g165860,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50540,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g165861,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50540,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g165862,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50540,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g165863,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50540,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g165864,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50540,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g165865,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50541,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g165866,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50541,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g165867,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50541,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g165868,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50541,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g165869,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50541,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g165870,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50542,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g165871,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50542,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g165872,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50542,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g165873,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50542,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g165874,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50542,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g165875,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50543,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g165876,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50543,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g165877,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50543,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g165878,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50543,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g165879,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50543,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g165880,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50544,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g165881,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50544,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g165882,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50544,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g165883,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50544,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g165884,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50544,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g165885,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50545,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g165886,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50545,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g165887,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50545,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g165888,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50545,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g165889,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50545,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g165890,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50546,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g165891,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50546,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g165892,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50546,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g165893,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50546,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g165894,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50546,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g165895,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50547,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g165896,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50547,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g165897,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50547,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g165898,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50547,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g165899,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50547,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g165900,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50548,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g165901,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50548,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g165902,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50548,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g165903,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50548,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g165904,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50548,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g165905,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50549,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g165906,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50549,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g165907,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50549,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g165908,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50549,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g165909,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50549,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g165910,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50550,0,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g165911,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50550,1,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g165912,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50550,2,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g165913,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50550,3,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g165914,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50550,4,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g165915,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50551,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g165916,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50551,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g165917,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50551,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g165918,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50551,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g165919,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50551,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g165920,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50552,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g165921,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50552,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g165922,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50552,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g165923,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50552,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g165924,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50552,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g165925,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50553,0,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g165926,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50553,1,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g165927,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50553,2,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g165928,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50553,3,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g165929,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50553,4,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g165930,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50554,0,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g165931,0,Excellent,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50554,1,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g165932,1,Very Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50554,2,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g165933,2,Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50554,3,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g165934,3,Fair,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50554,4,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g165935,4,Poor,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50555,0,"Overall, this activity was:",g165936,0,Excellent,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50555,1,"Overall, this activity was:",g165937,1,Very Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50555,2,"Overall, this activity was:",g165938,2,Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50555,3,"Overall, this activity was:",g165939,3,Fair,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50555,4,"Overall, this activity was:",g165940,4,Poor,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50556,0,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g165941,0,Yes,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50556,1,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g165942,1,No,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50556,2,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g165943,2,N/A,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,0,How would you improve this class?,g165944,0,Reduce content covered in class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,1,How would you improve this class?,g165945,1,Increase content covered in class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,2,How would you improve this class?,g165946,2,Update content covered in class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,3,How would you improve this class?,g165947,3,Improve the instructional methods,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,4,How would you improve this class?,g165948,4,Make course activities more stimulating,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,5,How would you improve this class?,g165949,5,Slow the pace of the class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15587,9881,Questions-0000-17,g9852,g50559,6,How would you improve this class?,g165950,6,"Other: (No changes needed; appropriate speaker, content, handouts, etc.)",0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSF MARCH  5TH & 6TH, 2020"
15570,9338,Elearning-0000-584,g9838,g50366,0,"I acknowledge that I have read the FY2020 Education Chain of Command CBL in its entirety, I understand the actions that I need to take to implement the chain of command as well as understanding the importance of communicating and expressing concerns and issues.  I also understand when an incident report needs to be submitted.",g165174,0,TRUE,1,FY2020 EDUCATION ON CHAIN OF COMMAND
15570,9338,Elearning-0000-584,g9838,g50366,1,"I acknowledge that I have read the FY2020 Education Chain of Command CBL in its entirety, I understand the actions that I need to take to implement the chain of command as well as understanding the importance of communicating and expressing concerns and issues.  I also understand when an incident report needs to be submitted.",g165175,1,FALSE,0,FY2020 EDUCATION ON CHAIN OF COMMAND
15565,9535,Elearning-0000-763,g9831,g50325,0,What gauge IV is preferred to perform a bubble study?,g165037,0,20G,1,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50325,1,What gauge IV is preferred to perform a bubble study?,g165038,1,22G,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50325,2,What gauge IV is preferred to perform a bubble study?,g165039,2,18G,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50326,0,Why do we perform bubble studies?,g165040,0,To evaluate ejection fraction,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50326,1,Why do we perform bubble studies?,g165041,1,to evaluate for possible ASD or other intracardiac shunts,1,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50326,2,Why do we perform bubble studies?,g165042,2,To assess for blood clots prior to cardioversion,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50327,0,Should you ever inject an air bolus,g165043,0,Yes,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50327,1,Should you ever inject an air bolus,g165044,1,No,1,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50328,0,How many attempts can you perform prior to notifying the physician for additional studies.,g165045,0,2,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50328,1,How many attempts can you perform prior to notifying the physician for additional studies.,g165046,1,3,1,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50328,2,How many attempts can you perform prior to notifying the physician for additional studies.,g165047,2,4,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50328,3,How many attempts can you perform prior to notifying the physician for additional studies.,g165048,3,5,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50329,0,You are injecting macro bubbles,g165049,0,TRUE,0,ECHO WITH BUBBLE STUDY EDUCATION FY20
15565,9535,Elearning-0000-763,g9831,g50329,1,You are injecting macro bubbles,g165050,1,FALSE,1,ECHO WITH BUBBLE STUDY EDUCATION FY20
15550,9129,Elearning-0000-394,g9824,g50306,0,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,g164978,0,0 ΓÇô 9,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50306,1,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,g164979,1,10 ΓÇô 20,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50306,2,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,g164980,2,50 ΓÇô 60,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50306,3,Approximately how many targeted oral antineoplastic agents have gained FDA approval in the last decade?,g164981,3,> 100,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50307,0,TKIs directly interfere with tyrosine kinase enzymes that are activated in tumor cells and are critical to tumor growth.,g164982,0,TRUE,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50307,1,TKIs directly interfere with tyrosine kinase enzymes that are activated in tumor cells and are critical to tumor growth.,g164983,1,FALSE,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50308,0,Which one of these are considered key oncogenic kinase drug targets:,g164984,0,EGFR,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50308,1,Which one of these are considered key oncogenic kinase drug targets:,g164985,1,HER2,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50308,2,Which one of these are considered key oncogenic kinase drug targets:,g164986,2,BRAF,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50308,3,Which one of these are considered key oncogenic kinase drug targets:,g164987,3,A and B,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50308,4,Which one of these are considered key oncogenic kinase drug targets:,g164988,4,A and C,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50309,0,Which statement is false?,g164989,0,Concomitant use of acid suppressive drugs can alter the bioavailability of some TKIs and significantly affect their absorption,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50309,1,Which statement is false?,g164990,1,"If possible, the combination of alectinib and an H2-antagonist, proton-pump inhibitor, or antacid should be avoided",0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50309,2,Which statement is false?,g164991,2,"All TKIs are fairly highly bound to plasma proteins (>90%), therefore these inhibitors are prone to interactions with other highly bound drugs",0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50309,3,Which statement is false?,g164992,3,Most TKIs undergo renal metabolism,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50310,0,Antineoplastic agents generally have a wide therapeutic window.,g164993,0,TRUE,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50310,1,Antineoplastic agents generally have a wide therapeutic window.,g164994,1,FALSE,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50311,0,Which of the following factors is not related to DDIs:,g164995,0,Pharmaceutic,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50311,1,Which of the following factors is not related to DDIs:,g164996,1,Pharmacoeconomic,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50311,2,Which of the following factors is not related to DDIs:,g164997,2,Pharmacodynamic,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50311,3,Which of the following factors is not related to DDIs:,g164998,3,Pharmacokinetic,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50312,0,Proton pump inhibitors (PPIs) lower gastric pH; therefore increase the absorption and bioavailability of certain oral antineoplastic agents.,g164999,0,TRUE,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50312,1,Proton pump inhibitors (PPIs) lower gastric pH; therefore increase the absorption and bioavailability of certain oral antineoplastic agents.,g165000,1,FALSE,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50313,0,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",g165001,0,Ruxolitinib,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50313,1,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",g165002,1,Sorafenib,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50313,2,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",g165003,2,Pazopanib,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50313,3,"Which of the following TKIs is most likely to cause digoxin toxicity due to PGP inhibition, if taken concurrently?",g165004,3,Afatinib,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50314,0,"Using a drug information resource, you determine that the administration of afatinib and a strong CYP3A4 inhibitor, such as posaconazole, is unsafe and should be avoided due to the risk of increased serum concentrations of afatinib:",g165005,0,TRUE,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50314,1,"Using a drug information resource, you determine that the administration of afatinib and a strong CYP3A4 inhibitor, such as posaconazole, is unsafe and should be avoided due to the risk of increased serum concentrations of afatinib:",g165006,1,FALSE,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50315,0,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,g165007,0,Severe myelosuppression secondary to inhibition of CYP3A4,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50315,1,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,g165008,1,Prolonged QTc interval,1,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50315,2,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,g165009,2,Lack of disease response due to induction of CYP3A4,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15550,9129,Elearning-0000-394,g9824,g50315,3,The concurrent use of dasatinib and ondansetron IV may warrant close monitoring of which clinically significant toxicity due to a potential DDI:,g165010,3,None of the above,0,FY2020 PHARMACY TKIS AND DRUG INTERACTIONS EDUCATION FOR ONCOLOGY
15551,9502,Elearning-0000-733,g9817,g50291,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164930,0,TRUE,1,CARE COORDINATION PNEUMONIA EDUCATION
15551,9502,Elearning-0000-733,g9817,g50291,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164931,1,FALSE,0,CARE COORDINATION PNEUMONIA EDUCATION
15549,9503,Elearning-0000-734,g9816,g50290,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164928,0,TRUE,1,CARE COORDINATION COPD EDUCATION
15549,9503,Elearning-0000-734,g9816,g50290,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164929,1,FALSE,0,CARE COORDINATION COPD EDUCATION
15543,9039,Elearning-0000-312,g9811,g50282,0,The OB Triage PowerForm is completed within the first two hours of the patientΓÇÖs admission and now the MD wants to transfer the patient to the high risk unit. What should be done prior to transfer?,g164907,0,Consult/referral screening,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50282,1,The OB Triage PowerForm is completed within the first two hours of the patientΓÇÖs admission and now the MD wants to transfer the patient to the high risk unit. What should be done prior to transfer?,g164908,1,Patient transfer to new unit,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50282,2,The OB Triage PowerForm is completed within the first two hours of the patientΓÇÖs admission and now the MD wants to transfer the patient to the high risk unit. What should be done prior to transfer?,g164909,2,Complete the entire OB Patient History PowerForm,1,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50283,0,Information that is documented in the OB Triage PowerForm will flow into the OB Patient History PowerForm.,g164910,0,TRUE,1,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50283,1,Information that is documented in the OB Triage PowerForm will flow into the OB Patient History PowerForm.,g164911,1,FALSE,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50284,0,The OB Triage PowerForm can be utilized in the following departments:,g164912,0,L&D,1,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50284,1,The OB Triage PowerForm can be utilized in the following departments:,g164913,1,HRP,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50284,2,The OB Triage PowerForm can be utilized in the following departments:,g164914,2,FCC,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50284,3,The OB Triage PowerForm can be utilized in the following departments:,g164915,3,All of above,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50285,0,"When completing the OB Risk Factors section of the admission PowerForm, you should:",g164916,0,Select the header,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50285,1,"When completing the OB Risk Factors section of the admission PowerForm, you should:",g164917,1,Select the individual risk factors,1,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50285,2,"When completing the OB Risk Factors section of the admission PowerForm, you should:",g164918,2,Select both the header and the risk factors,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50286,0,The expectation is that the entire OB Patient History PowerForm will be completed prior to transfer to another unit.,g164919,0,TRUE,1,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50286,1,The expectation is that the entire OB Patient History PowerForm will be completed prior to transfer to another unit.,g164920,1,FALSE,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50287,0,The entire OB Patient History PowerForm must be completed if the patient is not discharged within  ____  hours:,g164921,0,2 hours,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50287,1,The entire OB Patient History PowerForm must be completed if the patient is not discharged within  ____  hours:,g164922,1,4 hours,1,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15543,9039,Elearning-0000-312,g9811,g50287,2,The entire OB Patient History PowerForm must be completed if the patient is not discharged within  ____  hours:,g164923,2,6 hours,0,CERNER OB PATIENT HISTORY AND TRIAGE POWERFORMS
15538,9474,Elearning-0000-708,g9809,g50281,0,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,g164905,0,TRUE,1,CHEMOTHERAPY SPILL PROCEDURE
15538,9474,Elearning-0000-708,g9809,g50281,1,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,g164906,1,FALSE,0,CHEMOTHERAPY SPILL PROCEDURE
15530,9342,Elearning-0000-588,g9801,g50240,0,I verify that I have read and understand the expectations for practice audits in Surgical Services at Northside Hospital.,g164849,0,TRUE,1,FY20 PRACTICE AUDITS IN SURGICAL SERVICES
15530,9342,Elearning-0000-588,g9801,g50240,1,I verify that I have read and understand the expectations for practice audits in Surgical Services at Northside Hospital.,g164850,1,FALSE,0,FY20 PRACTICE AUDITS IN SURGICAL SERVICES
15521,8118,Elearning-0000-1016,g9793,g50172,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Inpatient CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164550,0,TRUE,1,NEUROSURGERY NURSING DOCUMENTATION - INPATIENT
15521,8118,Elearning-0000-1016,g9793,g50172,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Inpatient CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164551,1,FALSE,0,NEUROSURGERY NURSING DOCUMENTATION - INPATIENT
15520,8117,Elearning-0000-1015,g9792,g50171,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Surgical Services CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164548,0,TRUE,1,NEUROSURGERY NURSING DOCUMENTATION - SURGICAL SERVICES
15520,8117,Elearning-0000-1015,g9792,g50171,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the Neurosurgery Nursing Documentation - Surgical Services CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g164549,1,FALSE,0,NEUROSURGERY NURSING DOCUMENTATION - SURGICAL SERVICES
15515,9375,Elearning-0000-618,g9787,g50120,0,"1.	What does NEWT-OB stand for?",g164350,0,"a.	New Triggers for OB",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50120,1,"1.	What does NEWT-OB stand for?",g164351,1,"b.	Northside Early Warning Triggers for Obstetrics",1,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50120,2,"1.	What does NEWT-OB stand for?",g164352,2,"c.	Northside OB Early Warning",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50120,3,"1.	What does NEWT-OB stand for?",g164353,3,"d.	None of the Above",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50121,0,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",g164354,0,"a.	Notify the provider and request them to come to the bedside.",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50121,1,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",g164355,1,"b.	The patient has chronic hypertension so this is an expected BP. Continue to monitor.",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50121,2,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",g164356,2,"c.	Treat the patient according to the Labetalol orders and notify the provider.",1,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50121,3,"2.	A patient currently has a BP of 165/95. You repeat in 15 minutes and the BP is 166/98. You know patient has orders for IV Labetalol for BP's >/= 160/110. According to NEWT-OB what will your next actions be?",g164357,3,"d.	Treat the patient according to the Labetalol orders.",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50122,0,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",g164358,0,"a.	Notify the provider to request an emergent antihypertensive medication.",1,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50122,1,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",g164359,1,"b.	Recheck the BP in 15 more minutes",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50122,2,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",g164360,2,"c.	Turn the patient on their left side and recheck BP in one hour",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50122,3,"3.	Your patient has an elevated BP above the threshold of 160/110 that is sustained for 15 mins. This patient does not currently have an antihypertensive guideline order. What would your next nursing action be?",g164361,3,"d.	This patient has chronic hypertension so continue to monitor VS every 4 hours.",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50123,0,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",g164362,0,"a.	Notify the provider and assess VS every 4 hours until temperature abnormality resolves",1,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50123,1,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",g164363,1,"b.	Repeat a temperature only and notify provider if still elevated.",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50123,2,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",g164364,2,"c.	Check temperature hourly for the rest of your shift",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50123,3,"4.	The patient has a temperature elevation that is outside of the parameters set for your population and/or department. There are no other positive parameters. What should your nursing actions be?",g164365,3,"d.	Continue to monitor until the patient has 2 or more positive parameters.",0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50124,0,"5.	If MAP is the only positive parameter, the nurse should assess patient meets the sepsis criteria and notify the provider.",g164366,0,TRUE,1,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50124,1,"5.	If MAP is the only positive parameter, the nurse should assess patient meets the sepsis criteria and notify the provider.",g164367,1,FALSE,0,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50125,0,"6.	Documentation of if a NEWT-OB parameter is met should occur with each set of VS?",g164368,0,TRUE,1,FCC RESIDENCY NEWT-OB FY2020
15515,9375,Elearning-0000-618,g9787,g50125,1,"6.	Documentation of if a NEWT-OB parameter is met should occur with each set of VS?",g164369,1,FALSE,0,FCC RESIDENCY NEWT-OB FY2020
15514,9373,Elearning-0000-616,g9786,g50115,0,How frequently must vital signs be assessed after administering a PCA clinician bolus?,g164333,0,Q 2 hours x 4,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50115,1,How frequently must vital signs be assessed after administering a PCA clinician bolus?,g164334,1,Q 5 minutes x 5,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50115,2,How frequently must vital signs be assessed after administering a PCA clinician bolus?,g164335,2,Q 15 minutes x 2,1,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50115,3,How frequently must vital signs be assessed after administering a PCA clinician bolus?,g164336,3,Q 1 hour x 2,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50116,0,What are common side effects of an epidural or PCA?,g164337,0,Nausea,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50116,1,What are common side effects of an epidural or PCA?,g164338,1,Vomiting,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50116,2,What are common side effects of an epidural or PCA?,g164339,2,Numbness,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50116,3,What are common side effects of an epidural or PCA?,g164340,3,All of the above,1,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50117,0,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,g164341,0,Greater than 24 hours post-delivery and no reports of numbness,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50117,1,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,g164342,1,Able to tolerate solid food and pain should be under control per patient pain goal,1,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50117,2,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,g164343,2,Normal EKG and pain under control per patient goal,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50117,3,What 2 criteria must a patient meet prior to weaning from an epidural or PCA?,g164344,3,Vital signs stable and patient able to tolerate solid food,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50118,0,Severe or escalating pain out of proportion to the patientΓÇÖs progression towards recovery is a NEWT trigger.,g164345,0,TRUE,1,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50118,1,Severe or escalating pain out of proportion to the patientΓÇÖs progression towards recovery is a NEWT trigger.,g164346,1,FALSE,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50119,0,Which of the following are potential interventions for a patient experiencing epidural breakthrough pain?,g164347,0,Clinician bolus 2 x the PCA dose,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50119,1,Which of the following are potential interventions for a patient experiencing epidural breakthrough pain?,g164348,1,Morphine 2mg IV,0,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15514,9373,Elearning-0000-616,g9786,g50119,2,Which of the following are potential interventions for a patient experiencing epidural breakthrough pain?,g164349,2,All of the above,1,FCC RESIDENCY POSTPARTUM PAIN PART 2 FY2020
15512,251,SCORM-0000-61,g9785,g50114,0,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,g164331,0,TRUE,1,KINDNESS THROUGH COMMUNICATION: CONNECT
15512,251,SCORM-0000-61,g9785,g50114,1,I acknowledge that I have read this CBL in its entirety and understand that I am responsible for its content.,g164332,1,FALSE,0,KINDNESS THROUGH COMMUNICATION: CONNECT
15511,9609,Elearning-0000-830,g9784,g50111,0,"True or False: If the ΓÇ£Removal InstructionsΓÇ¥ field on the patientΓÇÖs urinary catheter order says ΓÇ£DC per Urinary Catheter Removal ProtocolΓÇ¥, then the MD has opted in to the nurse-driven removal protocol for that patient.",g164323,0,TRUE,1,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g50111,1,"True or False: If the ΓÇ£Removal InstructionsΓÇ¥ field on the patientΓÇÖs urinary catheter order says ΓÇ£DC per Urinary Catheter Removal ProtocolΓÇ¥, then the MD has opted in to the nurse-driven removal protocol for that patient.",g164324,1,FALSE,0,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g50112,0,How often should you assess the indication for indwelling urinary catheter if your patient is on the nurse-driven removal protocol?,g164325,0,a. Once a shift,1,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g50112,1,How often should you assess the indication for indwelling urinary catheter if your patient is on the nurse-driven removal protocol?,g164326,1,b. Once a day,0,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g50112,2,How often should you assess the indication for indwelling urinary catheter if your patient is on the nurse-driven removal protocol?,g164327,2,c. None of the above,0,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g50113,0,"If your patient does not spontaneously void within 6 hours after indwelling urinary catheter removal, you should:",g190576,0,"a.	Follow the ΓÇ£Bladder Scan GuidelinesΓÇ¥ and bladder scan & straight catheterize the patient as appropriate",1,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g50113,1,"If your patient does not spontaneously void within 6 hours after indwelling urinary catheter removal, you should:",g190577,1,"b.	Re-insert the indwelling urinary catheter",0,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g57539,0,The algorithm for the Urinary Catheter Removal Protocol is available in:,g190578,0,"a.	Cerner",0,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g57539,1,The algorithm for the Urinary Catheter Removal Protocol is available in:,g190579,1,"b.	Lucidoc",0,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15511,9609,Elearning-0000-830,g9784,g57539,2,The algorithm for the Urinary Catheter Removal Protocol is available in:,g190580,2,"c.	Both of the above",1,FY2021 URINARY CATHETER REMOVAL PROTOCOL
15504,9372,Elearning-0000-615,g9777,g50022,0,Which of the following can influence a patientΓÇÖs perception of pain?,g164054,0,Culture,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50022,1,Which of the following can influence a patientΓÇÖs perception of pain?,g164055,1,Anxiety,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50022,2,Which of the following can influence a patientΓÇÖs perception of pain?,g164056,2,Previous experiences,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50022,3,Which of the following can influence a patientΓÇÖs perception of pain?,g164057,3,Physiologic factors,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50022,4,Which of the following can influence a patientΓÇÖs perception of pain?,g164058,4,All of the above,1,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50023,0,What does it mean if a patient is ΓÇ£opioid na├»veΓÇ¥?,g164059,0,The patient has previously taken opioids and their body may require larger doses Medication to achieve pain relief,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50023,1,What does it mean if a patient is ΓÇ£opioid na├»veΓÇ¥?,g164060,1,The patient has had no previous exposure to opioids and may require less medication to achieve pain relief.,1,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50023,2,What does it mean if a patient is ΓÇ£opioid na├»veΓÇ¥?,g164061,2,The patient does not know what opioids are.,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50023,3,What does it mean if a patient is ΓÇ£opioid na├»veΓÇ¥?,g164062,3,The patient is allergic to opioids.,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50024,0,How frequently should pain be assessed?,g164063,0,Within the first two hours of your shift,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50024,1,How frequently should pain be assessed?,g164064,1,With every assessment,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50024,2,How frequently should pain be assessed?,g164065,2,Within 1 hour after any intervention for pain,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50024,3,How frequently should pain be assessed?,g164066,3,All of the above,1,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50025,0,All scheduled medications (i.e. Motrin) should be reassessed within 1 hour after administration.,g164067,0,TRUE,1,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50025,1,All scheduled medications (i.e. Motrin) should be reassessed within 1 hour after administration.,g164068,1,FALSE,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50026,0,Which of the following situations always requires a second RN co-signature?,g164069,0,Changing an epidural cassette,1,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50026,1,Which of the following situations always requires a second RN co-signature?,g164070,1,Administration of a narcotic,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50026,2,Which of the following situations always requires a second RN co-signature?,g164071,2,Discontinuing an epidural,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50026,3,Which of the following situations always requires a second RN co-signature?,g164072,3,Documentation of a pain score,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50027,0,How frequently should a patient with an epidural be assessed?,g164073,0,Every shift,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50027,1,How frequently should a patient with an epidural be assessed?,g164074,1,Every 2 hours,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50027,2,How frequently should a patient with an epidural be assessed?,g164075,2,Every 4 hours,1,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15504,9372,Elearning-0000-615,g9777,g50027,3,How frequently should a patient with an epidural be assessed?,g164076,3,Every 8 hours,0,FCC RESIDENCY  POSTPARTUM PAIN PART 1 FY2020
15463,9152,Elearning-0000-415,g9742,g49818,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163398,0,TRUE,1,2020 CPT UPDATES
15463,9152,Elearning-0000-415,g9742,g49818,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163399,1,FALSE,0,2020 CPT UPDATES
15458,8124,Elearning-0000-1021,g9738,g49807,0,The Initial Preventive Physical Exam is an introduction to Medicare.,g163370,0,TRUE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49807,1,The Initial Preventive Physical Exam is an introduction to Medicare.,g163371,1,FALSE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49808,0,IPPE should be completed within the first 8 months of Medicare Part B coverage.,g163372,0,TRUE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49808,1,IPPE should be completed within the first 8 months of Medicare Part B coverage.,g163373,1,FALSE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49809,0,IPPE is a one-time benefit for new Medicare beneficiaries.,g163374,0,TRUE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49809,1,IPPE is a one-time benefit for new Medicare beneficiaries.,g163375,1,FALSE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49810,0,IPPE is billed with HCPCS code:,g163376,0,A) G0402,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49810,1,IPPE is billed with HCPCS code:,g163377,1,B) G0403,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49810,2,IPPE is billed with HCPCS code:,g163378,2,C) 99387,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49810,3,IPPE is billed with HCPCS code:,g163379,3,D) G0439,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49810,4,IPPE is billed with HCPCS code:,g163380,4,E) G0438,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49811,0,Which component of the IPPE must be performed prior to submitting a claim for the service?,g163381,0,A) Review the patientΓÇÖs medical and social history,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49811,1,Which component of the IPPE must be performed prior to submitting a claim for the service?,g163382,1,B) Review of functional ability and level of safety,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49811,2,Which component of the IPPE must be performed prior to submitting a claim for the service?,g163383,2,C) Examination,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49811,3,Which component of the IPPE must be performed prior to submitting a claim for the service?,g163384,3,"D) End-of-life planning, upon agreement of individual",0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49811,4,Which component of the IPPE must be performed prior to submitting a claim for the service?,g163385,4,E) All of the above,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49812,0,"If patient is no longer within first 12 months after the effective date of their first Medicare Part B coverage period and has not received either an IPPE or AWV within the past 12 months, Medicare will cover an initial AWV.",g163386,0,TRUE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49812,1,"If patient is no longer within first 12 months after the effective date of their first Medicare Part B coverage period and has not received either an IPPE or AWV within the past 12 months, Medicare will cover an initial AWV.",g163387,1,FALSE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49813,0,The <u>Routine</u> AWV Component applies to the first time a patient receives an AWV.,g163388,0,TRUE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49813,1,The <u>Routine</u> AWV Component applies to the first time a patient receives an AWV.,g163389,1,FALSE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49814,0,The <u>Subsequent</u> AWV Component applies for all subsequent AWVs after a patientΓÇÖs first AWV.,g163390,0,TRUE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49814,1,The <u>Subsequent</u> AWV Component applies for all subsequent AWVs after a patientΓÇÖs first AWV.,g163391,1,FALSE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49815,0,"Generally, other services may be reported on the same day as long as there is sufficient stand alone documentation to support these services.",g163392,0,TRUE,1,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49815,1,"Generally, other services may be reported on the same day as long as there is sufficient stand alone documentation to support these services.",g163393,1,FALSE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49816,0,An additional Evaluation and Management (E/M) service may not be billed when a significant and separately identifiable service is performed along with the IPPE/AWV.,g163394,0,TRUE,0,IPPE/AWV
15458,8124,Elearning-0000-1021,g9738,g49816,1,An additional Evaluation and Management (E/M) service may not be billed when a significant and separately identifiable service is performed along with the IPPE/AWV.,g163395,1,FALSE,1,IPPE/AWV
15456,9797,Questions-0000-03,g9735,g49760,0,Please list the location for this activity.,g163180,0,Atlanta,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49760,1,Please list the location for this activity.,g163181,1,Forsyth,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49760,2,Please list the location for this activity.,g163182,2,Cherokee,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49760,3,Please list the location for this activity.,g163183,3,Other,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49761,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",g163184,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49761,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",g163185,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49761,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",g163186,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49761,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",g163187,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49761,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the relationship between the electrical physiology and functional anatomy of the heart.</ol>",g163188,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49762,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",g163189,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49762,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",g163190,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49762,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",g163191,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49762,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",g163192,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49762,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss the basic premise of electrophysiology and waveform deflection.   </ol>",g163193,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49763,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",g163194,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49763,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",g163195,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49763,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",g163196,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49763,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",g163197,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49763,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify appropriate electrode placements for each individual lead on a 12 lead EKG. </ol>",g163198,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49764,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",g163199,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49764,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",g163200,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49764,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",g163201,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49764,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",g163202,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49764,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the pathological difference between zones of ischemia, injury and infarction.</ol>",g163203,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49765,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",g163204,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49765,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",g163205,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49765,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",g163206,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49765,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",g163207,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49765,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize the EKG characteristic differences of the patterns of ischemia, injury and infarction. </ol>",g163208,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49766,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",g163209,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49766,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",g163210,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49766,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",g163211,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49766,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",g163212,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49766,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify areas of myocardial ischemia by assessment of the 12 lead EKG. </ol>",g163213,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49767,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,g163214,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49767,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,g163215,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49767,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,g163216,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49767,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,g163217,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49767,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL><OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL> .</OL>,g163218,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49768,0,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",g163219,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49768,1,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",g163220,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49768,2,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",g163221,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49768,3,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",g163222,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49768,4,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented has increased my knowledge of 12 Lead EKG analysis and will help me to identify patterns of ischemia, injury and infarction as well as identify the area of myocardial damage by assessment and analysis of the 12 Lead EKG.</OL>",g163223,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49769,0,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g163224,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49769,1,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g163225,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49769,2,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g163226,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49769,3,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g163227,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49769,4,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g163228,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49770,0,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",g163229,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49770,1,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",g163230,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49770,2,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",g163231,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49770,3,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",g163232,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49770,4,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was balanced, objective and scientifically rigorous.</ol>",g163233,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49771,0,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g163234,0,Strongly Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49771,1,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g163235,1,Agree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49771,2,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g163236,2,No Opinion,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49771,3,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g163237,3,Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49771,4,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g163238,4,Strongly Disagree,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49772,0,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",g163239,0,Excellent,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49772,1,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",g163240,1,Very Good,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49772,2,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",g163241,2,Good,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49772,3,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",g163242,3,Fair,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49772,4,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN</ol>",g163243,4,Poor,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49773,0,"Overall, this activity was:",g163244,0,Excellent,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49773,1,"Overall, this activity was:",g163245,1,Very Good,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49773,2,"Overall, this activity was:",g163246,2,Good,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49773,3,"Overall, this activity was:",g163247,3,Fair,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49773,4,"Overall, this activity was:",g163248,4,Poor,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49774,0,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g163249,0,Yes,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49774,1,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g163250,1,No,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49774,2,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g163251,2,N/A,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,0,How would you improve this class?,g163252,0,Reduce content covered in class,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,1,How would you improve this class?,g163253,1,Increase content covered in class,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,2,How would you improve this class?,g163254,2,Update content covered in class,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,3,How would you improve this class?,g163255,3,Improve the instructional methods,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,4,How would you improve this class?,g163256,4,Make course activities more stimulating,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,5,How would you improve this class?,g163257,5,Slow the pace of the class,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15456,9797,Questions-0000-03,g9735,g49777,6,How would you improve this class?,g163258,6,Other,0,"12 LEAD EKG ANALYSIS PART 1- ASSESSING PATTERNS OF ISCHEMIA, INJURY AND INFARCTION NSA 2.4.20 (EVALUATION SURVEY)"
15453,9095,Elearning-0000-363,g9732,g49737,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163094,0,TRUE,1,NSH1208 AMENDMENT 2
15453,9095,Elearning-0000-363,g9732,g49737,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163095,1,FALSE,0,NSH1208 AMENDMENT 2
15452,9099,Elearning-0000-367,g9731,g49736,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163092,0,TRUE,1,NSH1205 AMENDMENT 4
15452,9099,Elearning-0000-367,g9731,g49736,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163093,1,FALSE,0,NSH1205 AMENDMENT 4
15450,9519,Elearning-0000-749,g9729,g49713,0,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163001,0,TRUE,1,C-378 VERSION 11.15.19
15450,9519,Elearning-0000-749,g9729,g49713,1,"For questions about these statements, contact your manager.<br><br>  I have reviewed the <CBL Name> CBL content.<br> I understand that I am responsible for the information.<br> I understand that I should stop in the face of uncertainty and ask for clarification.<br> I know where and how to get my questions answered about this topic.",g163002,1,FALSE,0,C-378 VERSION 11.15.19
15449,9962,Questions-0000-96,g9728,g49688,0,Please list the location for this activity.,g162892,0,Atlanta,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49688,1,Please list the location for this activity.,g162893,1,Forsyth,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49688,2,Please list the location for this activity.,g162894,2,Cherokee,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49688,3,Please list the location for this activity.,g162895,3,Other,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49689,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  ΓÇ£ Life is Why ΓÇ£ campaign. </ol>",g162896,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49689,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  ΓÇ£ Life is Why ΓÇ£ campaign. </ol>",g162897,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49689,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  ΓÇ£ Life is Why ΓÇ£ campaign. </ol>",g162898,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49689,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  ΓÇ£ Life is Why ΓÇ£ campaign. </ol>",g162899,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49689,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the American Heart Association  ΓÇ£ Life is Why ΓÇ£ campaign. </ol>",g162900,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49690,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",g162901,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49690,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",g162902,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49690,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",g162903,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49690,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",g162904,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49690,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe major PALS science changes in 2015. </ol>",g162905,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49691,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",g162906,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49691,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",g162907,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49691,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",g162908,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49691,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",g162909,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49691,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to perform pediatric assessment to include primary and secondary assessment. </ol>",g162910,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49692,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",g162911,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49692,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",g162912,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49692,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",g162913,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49692,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",g162914,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49692,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early management of peri - arrest conditions that may result in respiratory/cardiac arrest or complicate resuscitation outcomes. </ol>",g162915,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49693,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g162916,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49693,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g162917,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49693,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g162918,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49693,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g162919,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49693,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g162920,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49694,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",g162921,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49694,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",g162922,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49694,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",g162923,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49694,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",g162924,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49694,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe the four categories of respiratory issues in the pediatric population along with causes, signs and symptoms of different respiratory disorders as well as management.</ol>",g162925,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49695,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",g162926,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49695,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",g162927,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49695,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",g162928,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49695,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",g162929,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49695,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to identify the four categories of shock seen in pediatric patients to include causes, signs and symptoms and management of the different types of shock.</ol>",g162930,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49696,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",g162931,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49696,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",g162932,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49696,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",g162933,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49696,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",g162934,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49696,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe compensated versus uncompensated shock.</ol>",g162935,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49697,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",g162936,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49697,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",g162937,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49697,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",g162938,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49697,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",g162939,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49697,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest to include dysrhythmias that cause cardiac arrest, bradycardias and tachycardias, manage cardiac arrest until termination of resuscitation or transfer of care.</ol>",g162940,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49698,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g162941,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49698,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g162942,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49698,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g162943,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49698,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g162944,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49698,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g162945,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49699,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post ΓÇô resuscitation care.</ol>",g162946,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49699,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post ΓÇô resuscitation care.</ol>",g162947,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49699,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post ΓÇô resuscitation care.</ol>",g162948,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49699,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post ΓÇô resuscitation care.</ol>",g162949,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49699,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage immediate post ΓÇô resuscitation care.</ol>",g162950,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49700,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",g162951,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49700,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",g162952,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49700,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",g162953,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49700,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",g162954,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49700,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe resuscitative skills required to complete the megacode station. </ol>",g162955,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49701,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g162956,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49701,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g162957,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49701,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g162958,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49701,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g162959,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49701,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g162960,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49702,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,g162961,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49702,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,g162962,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49702,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,g162963,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49702,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,g162964,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49702,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered has increased my knowledge and confidence in dealing with pediatric emergencies and cardiac arrest.</OL>,g162965,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49703,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g162966,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49703,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g162967,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49703,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g162968,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49703,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g162969,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49703,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g162970,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49704,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,g162971,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49704,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,g162972,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49704,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,g162973,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49704,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,g162974,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49704,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to pass the Megacode station and the post-test. </OL>,g162975,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49705,0,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g162976,0,Strongly Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49705,1,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g162977,1,Agree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49705,2,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g162978,2,No Opinion,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49705,3,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g162979,3,Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49705,4,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g162980,4,Strongly Disagree,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49706,0,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g162981,0,Excellent,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49706,1,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g162982,1,Very Good,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49706,2,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g162983,2,Good,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49706,3,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g162984,3,Fair,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49706,4,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN, CCRN </ol>",g162985,4,Poor,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49707,0,"Overall, this activity was:",g162986,0,Excellent,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49707,1,"Overall, this activity was:",g162987,1,Very Good,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49707,2,"Overall, this activity was:",g162988,2,Good,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49707,3,"Overall, this activity was:",g162989,3,Fair,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49707,4,"Overall, this activity was:",g162990,4,Poor,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49708,0,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g162991,0,Yes,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49708,1,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g162992,1,No,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49708,2,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g162993,2,N/A,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,0,How would you improve this class?,g162994,0,Reduce content covered in class,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,1,How would you improve this class?,g162995,1,Increase content covered in class,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,2,How would you improve this class?,g162996,2,Update content covered in class,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,3,How would you improve this class?,g162997,3,Improve the instructional methods,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,4,How would you improve this class?,g162998,4,Make course activities more stimulating,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,5,How would you improve this class?,g162999,5,Slow the pace of the class,0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15449,9962,Questions-0000-96,g9728,g49711,6,How would you improve this class?,g163000,6,"Other: (No changes needed; appropriate speaker, content, handouts, etc.)",0,"PEDIATRIC ADVANCED LIFE SUPPORT (PALS) INITIAL PROVIDER COURSE(EVALUATION SURVEY) NSA JAN. 30 & 31, 2020"
15423,8120,Elearning-0000-1018,g9706,g49570,0,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,g162431,0,"1.	A valve mechanism",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49570,1,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,g162432,1,"2.	An IV catheter",1,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49570,2,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,g162433,2,"3.	An outflow or distal catheter",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49570,3,What is <b><u>NOT</u></b> a component of a shunt system for Hydrocephalus?,g162434,3,"4.	An inflow or proximal catheter",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49571,0,What are complications of a shunt placement?,g162435,0,"1.	Malfunction",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49571,1,What are complications of a shunt placement?,g162436,1,"2.	Infection",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49571,2,What are complications of a shunt placement?,g162437,2,"3.	Material Degradation",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49571,3,What are complications of a shunt placement?,g162438,3,"4.	Seizures",0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49571,4,What are complications of a shunt placement?,g162439,4,"5.	All of the above",1,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49572,0,"A patient presenting to the ED with vomiting, headache, vision problems. Lethargy, irritability and new onset of gait problems, he had a VP shunt placed 6 month ago after a subarachnoid hemorrhage. Do you expect one of the differential diagnosis to be <i>shunt malfunction</i>?",g162440,0,1. Yes,1,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15423,8120,Elearning-0000-1018,g9706,g49572,1,"A patient presenting to the ED with vomiting, headache, vision problems. Lethargy, irritability and new onset of gait problems, he had a VP shunt placed 6 month ago after a subarachnoid hemorrhage. Do you expect one of the differential diagnosis to be <i>shunt malfunction</i>?",g162441,1,2. No,0,MANAGEMENT OF HYDROCEPHALUS - VP SHUNT
15412,9769,Elearning-0000-976,g9700,g49423,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161897,0,No needs identified,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161898,1,Adolescent 17 years or younger,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161899,2,Identify need for community resources,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161900,3,Pt/neonate with possible alcohol/drug screen,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161901,4,Pt verbalizes drug use during pregnancy,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161902,5,Both A and B,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161903,6,"B, D and E",1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49423,7,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Care Coordination:,g161904,7,All of the above,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161905,0,No needs identified,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161906,1,Substance abuse,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161907,2,Displays disorientation inconsistent with diagnosis,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161908,3,Displays delusional/disorganized thinking,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161909,4,Receiving outpatient Mental Health Services,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161910,5,Active suicidal/homicidal thoughts or plans,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161911,6,Pt has experienced catastrophic diagnosis,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,7,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161912,7,Depressed mood,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49424,8,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Behavioral Health:,g161913,8,Prominent anxiety,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49425,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,g161914,0,No needs identified,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49425,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,g161915,1,"Decline in gait, transfer, balance, or mobility skills",0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49425,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,g161916,2,"Decrease in strength, ROM or endurance",0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49425,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Physical Therapy:,g161917,3,Acute increase in musculoskeletal pain,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161918,0,No needs identified,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161919,1,Adaptive equipment,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161920,2,Diminishing self care,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161921,3,Impaired movement UE,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161922,4,Impaired movement LE,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161923,5,Unable to dress,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49426,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Occupational Therapy:,g161924,6,Unable to feed,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161925,0,No needs identified,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161926,1,Multiple gestation,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161927,2,Excessive weight gain,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161928,3,Progressive weight loss,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161929,4,Pregnant less than 17 years old,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161930,5,All of the above,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49427,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Clinical Nutrition:,g161931,6,Only B and E,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161932,0,No needs identified,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161933,1,Diabetic Ketoacidosis,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161934,2,Gestational Diabetes Mellitus,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161935,3,Pre Diabetes,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161936,4,PCOS,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161937,5,Type 1 Diabetes Mellitus,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49428,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Diabetes Education:,g161938,6,Type 2 Diabetes Mellitus,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49429,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,g161939,0,No needs identified,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49429,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,g161940,1,CPAP check,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49429,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,g161941,2,CPAP order,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49429,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Respiratory Therapy:,g161942,3,Smoking cessation,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161943,0,No needs identified,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161944,1,Perinatal loss,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161945,2,Newborn with congenital anomaly,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161946,3,Pt/family request,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161947,4,Pt/family experiencing spiritual distress,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161948,5,Pt/family experiencing catastrophic diagnosis,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49430,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pastoral Care:,g161949,6,Newborn for adoption,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49431,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Lactation:,g161950,0,No needs identified,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49431,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Lactation:,g161951,1,History of breast surgery/biopsy,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49432,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pharmacy:,g161952,0,No needs identified,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49432,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for Consults/Referrals on admission. Select all that apply to Pharmacy:,g161953,1,Medication Education,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49433,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,g161954,0,No history of receiving Tdap vaccine this pregnancy AND patient is pregnant between 27 and 0/7 weeks and 38 and 0/7 weeks,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49433,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,g161955,1,Patient is currently pregnant at 26 and 6/7 weeks gestation or earlier,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49433,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,g161956,2,Patient is currently pregnant at 38 and 1/7 weeks or greater,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49433,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,g161957,3,Has received Tdap vaccine this pregnancy,1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49433,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,g161958,4,"History of previous serious reaction to tetanus, diphtheria, or pertussis vaccine",0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49433,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Tdap vaccine on discharge. Patricia states she received the Tdap vaccine at 30 weeks gestation in the office. You confirm this is true on her prenatal record. Make the appropriate selection for the screening.,g161959,5,Patient educated but declines vaccine,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,0,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161960,0,No history of immunization this flu season (October1-March 31),0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,1,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161961,1,Patient uncertain of history of immunization unreliable this flu season (October 1- March 31),0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,2,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161962,2,Not currently flu Season (April 1- September 30),1,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,3,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161963,3,Previously immunized this flu season,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,4,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161964,4,Anaphylactic reaction to eggs,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,5,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161965,5,History of Guillain Barre Syndrome,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,6,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161966,6,Bone marrow transplant within last 6 months,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15412,9769,Elearning-0000-976,g9700,g49434,7,You are completing the antepartum portion of patient Patricia PetersonΓÇÖs OB Screening for the Influenza vaccine on discharge. (Hint: Remember the date of admission is 8/5/2019). Make the appropriate selection for the screening.,g161967,7,Patient educated but declines vaccine,0,NSF PRETERM LABOR COMPETENCY 2019-2020
15408,9111,Elearning-0000-378,g9694,g49399,0,The Court order should be provided by the attorney to the legal department prior to the surrogates admission to the hospital.,g161803,0,TRUE,1,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49399,1,The Court order should be provided by the attorney to the legal department prior to the surrogates admission to the hospital.,g161804,1,FALSE,0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49400,0,The surrogate signs the consents for the infant(s).,g161805,0,"A.	True",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49400,1,The surrogate signs the consents for the infant(s).,g161806,1,"B.	False",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49400,2,The surrogate signs the consents for the infant(s).,g161807,2,"C.	Only in the event that the court order is not yet on file.",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49400,3,The surrogate signs the consents for the infant(s).,g161808,3,"D.	Only if the court order is not on file and she has not signed a POA for the infant(s).",1,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49401,0,The baby bands are placed on ________,g161809,0,"A.	The surrogate and one legal parent",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49401,1,The baby bands are placed on ________,g161810,1,"B.	The legal parents",1,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49401,2,The baby bands are placed on ________,g161811,2,"C.	The surrogate",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49402,0,If the legal parents are not in the hospital at the time of birth what is done with the bands?,g161812,0,"A.	The surrogate receives both bands until the legal parents arrival, at which time one band is removed and placed on one of the legal parents.",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49402,1,If the legal parents are not in the hospital at the time of birth what is done with the bands?,g161813,1,"B.	The surrogate receives both bands and they remain in place until her discharge.",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49402,2,If the legal parents are not in the hospital at the time of birth what is done with the bands?,g161814,2,"C.	The surrogate receives both bands until the legal parents arrival, at which time her bands are removed and the legal parents are banded.",1,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49403,0,Once the baby(s) are banded they are admitted in _____________.,g161815,0,"A.	The surrogates room",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49403,1,Once the baby(s) are banded they are admitted in _____________.,g161816,1,"B.	The Nursery",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49403,2,Once the baby(s) are banded they are admitted in _____________.,g161817,2,"C.	The Nursery, unless the legal parents request for the baby to remain in the surrogates room.",1,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49404,0,Visitation with the baby by the surrogate_________________.,g161818,0,"A.	Is at the discretion of the legal parents in the nursery.",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49404,1,Visitation with the baby by the surrogate_________________.,g161819,1,"B.	Is at the discretion of the legal parents in their room.",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49404,2,Visitation with the baby by the surrogate_________________.,g161820,2,"C.	Is at the discretion of the legal parents in the surrogates room.",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49404,3,Visitation with the baby by the surrogate_________________.,g161821,3,D. Both A & B,1,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49405,0,Can the surrogate bring her family in to see the infant(s)?,g161822,0,"A.	Yes",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49405,1,Can the surrogate bring her family in to see the infant(s)?,g161823,1,"B.	No",0,NSC LD - SURROGACY IN LD
15408,9111,Elearning-0000-378,g9694,g49405,2,Can the surrogate bring her family in to see the infant(s)?,g161824,2,"C.	Only with the permission of the legal parents",1,NSC LD - SURROGACY IN LD
15400,9467,Elearning-0000-701,g9687,g49329,0,"How many babies are born annually with a cleft lip, with or without a palate defect?",g161534,0,"a.	3500",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49329,1,"How many babies are born annually with a cleft lip, with or without a palate defect?",g161535,1,"b.	7000",1,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49329,2,"How many babies are born annually with a cleft lip, with or without a palate defect?",g161536,2,"c.	6000",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49329,3,"How many babies are born annually with a cleft lip, with or without a palate defect?",g161537,3,"d.	2000",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49330,0,True or false: A baby with a cleft palate is able to exclusively breastfeed?,g161538,0,TRUE,0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49330,1,True or false: A baby with a cleft palate is able to exclusively breastfeed?,g161539,1,FALSE,1,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49331,0,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,g161540,0,"a.	Difficult to clean and sterilize",1,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49331,1,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,g161541,1,"b.	Only system to allow assist-delivery",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49331,2,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,g161542,2,"c.	Has variable flow rate controlled by the feeder",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49331,3,What is a disadvantage or con of using the Medela SNF (Haberman) bottle?,g161543,3,"d.	They have a smaller teat for premature infants",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49332,0,What surgery may be done before the child reaches school age?,g161544,0,"a.	Final repairs to the lip or palate",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49332,1,What surgery may be done before the child reaches school age?,g161545,1,"b.	Repair of scar tissue",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49332,2,What surgery may be done before the child reaches school age?,g161546,2,"c.	Upper gum repair using a bone graft",0,CLEFT LIP & PALATE 2020
15400,9467,Elearning-0000-701,g9687,g49332,3,What surgery may be done before the child reaches school age?,g161547,3,"d.	Nasal tip reconstruction and a revision of the lip scar",1,CLEFT LIP & PALATE 2020
15401,9870,Questions-0000-16,g9686,g49303,0,Please list the location for this activity.,g161425,0,Atlanta,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49303,1,Please list the location for this activity.,g161426,1,Forsyth,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49303,2,Please list the location for this activity.,g161427,2,Cherokee,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49303,3,Please list the location for this activity.,g161428,3,Other,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49304,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g161429,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49304,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g161430,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49304,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g161431,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49304,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g161432,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49304,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe meaning of ΓÇ£ Life is Why ΓÇ£ campaign by AHA. </ol>",g161433,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49305,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g161434,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49305,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g161435,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49305,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g161436,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49305,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g161437,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49305,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to perform a Primary and Secondary Survey. </ol>",g161438,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49306,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g161439,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49306,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g161440,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49306,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g161441,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49306,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g161442,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49306,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage respiratory arrest. </ol>",g161443,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49307,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g161444,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49307,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g161445,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49307,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g161446,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49307,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g161447,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49307,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate proficiency in providing BLS care, including prioritizing chest compressions and integrating use of an automated external defibrillator (AED). </ol>",g161448,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49308,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g161449,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49308,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g161450,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49308,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g161451,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49308,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g161452,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49308,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to discuss basic cardiac anatomy and physiology, identify criteria for normal and abnormal cardiac rhythms.</ol>",g161453,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49309,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g161454,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49309,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g161455,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49309,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g161456,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49309,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g161457,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49309,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to demonstrate effective communication as a member or leader of a resuscitation team and recognize the impact of team dynamics on overall team performance.</ol>",g161458,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49310,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g161459,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49310,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g161460,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49310,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g161461,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49310,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g161462,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49310,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize cardiac arrest and perform early management until termination of resuscitation or transfer of care. </ol>",g161463,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49311,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g161464,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49311,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g161465,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49311,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g161466,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49311,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g161467,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49311,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and manage return of spontaneous circulation (ROSC). </ol>",g161468,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49312,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g161469,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49312,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g161470,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49312,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g161471,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49312,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g161472,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49312,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage bradycardias and tachycardias that may result in cardiac arrest. </ol>",g161473,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49313,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g161474,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49313,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g161475,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49313,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g161476,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49313,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g161477,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49313,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and manage cardiac arrest in Megacode  teaching scenario, both as a team leader and team member. </ol>",g161478,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49314,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g161479,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49314,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g161480,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49314,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g161481,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49314,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g161482,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49314,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to recognize and initiate early treatment of ACS to include access to health care systems by calling 911 and appropriate disposition.</ol>",g161483,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49315,0,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g161484,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49315,1,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g161485,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49315,2,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g161486,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49315,3,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g161487,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49315,4,"<ol><b>LEARNING OBJECTIVES</b></ol> <ol>After attending this activity, I am better able to describe how to recognize and initiate early management of stroke, including appropriate disposition. </ol>",g161488,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49316,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g161489,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49316,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g161490,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49316,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g161491,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49316,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g161492,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49316,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content presented will help me to improve patient care.</OL>,g161493,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49317,0,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g161494,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49317,1,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g161495,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49317,2,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g161496,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49317,3,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g161497,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49317,4,"<OL><B>ACTIVITY CONTENT</B></OL> <OL>The content covered is useful, timely, and relevant to my practice.</OL>",g161498,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49318,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g161499,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49318,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g161500,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49318,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g161501,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49318,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g161502,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49318,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity was free of commercial bias.</OL>,g161503,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49319,0,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g161504,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49319,1,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g161505,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49319,2,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g161506,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49319,3,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g161507,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49319,4,<OL><B>ACTIVITY CONTENT</B></OL> <OL>This activity has  prepared me to better respond to emergency situations and cardiac arrest in selected-patient population.</OL>,g161508,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49320,0,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g161509,0,Strongly Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49320,1,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g161510,1,Agree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49320,2,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g161511,2,No Opinion,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49320,3,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g161512,3,Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49320,4,<OL><B>SETTING</B></OL> <OL>Facility was appropriate for the activity.</ol>,g161513,4,Strongly Disagree,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49321,0,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",g161514,0,Excellent,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49321,1,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",g161515,1,Very Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49321,2,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",g161516,2,Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49321,3,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",g161517,3,Fair,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49321,4,"<ol><b>EFFECTIVENESS OF SPEAKER</B></OL>  <ol>Please rate the effectiveness of Cindy White, MSN, RN</ol>",g161518,4,Poor,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49322,0,"Overall, this activity was:",g161519,0,Excellent,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49322,1,"Overall, this activity was:",g161520,1,Very Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49322,2,"Overall, this activity was:",g161521,2,Good,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49322,3,"Overall, this activity was:",g161522,3,Fair,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49322,4,"Overall, this activity was:",g161523,4,Poor,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49323,0,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g161524,0,Yes,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49323,1,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g161525,1,No,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49323,2,"<ol><b>ACTIVITY OUTCOMES</B></OL> <OL>Has this activity closed gaps in your knowledge, skill, or practice?",g161526,2,N/A,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,0,How would you improve this class?,g161527,0,Reduce content covered in class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,1,How would you improve this class?,g161528,1,Increase content covered in class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,2,How would you improve this class?,g161529,2,Update content covered in class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,3,How would you improve this class?,g161530,3,Improve the instructional methods,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,4,How would you improve this class?,g161531,4,Make course activities more stimulating,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,5,How would you improve this class?,g161532,5,Slow the pace of the class,0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
15401,9870,Questions-0000-16,g9686,g49326,6,How would you improve this class?,g161533,6,"Other: (No changes needed; appropriate speaker, content, handouts, etc.)",0,"ADVANCED CARDIAC LIFE SUPPORT (ACLS) INITIAL PROVIDER COURSE (EVALUATION SURVEY) NSA JAN. 23RD & 24TH, 2020"
